Solvonis Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	2017 - 2019
Period Ending	Sep '25 Sep 10, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	May '21 May 31, 2021	2017 - 2019
Market Capitalization	16	5	1	14	-	-	Upgrade
Market Cap Growth	686.33%	686.33%	-95.86%	-	-	-	Upgrade
Enterprise Value	15	5	0	11	-	-	Upgrade
Last Close Price	0.00	0.00	0.01	0.14	-	-	Upgrade
PS Ratio	-	-	1.02	26.70	-	-	Upgrade
PB Ratio	5.07	1.53	0.30	3.18	-	-	Upgrade
P/TBV Ratio	15.69	4.73	-	5.82	-	-	Upgrade
EV/Sales Ratio	-	-	0.20	21.08	-	-	Upgrade
Debt / Equity Ratio	-	-	0.02	0.01	1.18	0.52	Upgrade
Asset Turnover	-	-	0.16	0.13	-	0.20	Upgrade
Inventory Turnover	-	-	3.75	-	-	-	Upgrade
Quick Ratio	6.66	6.66	0.63	4.74	0.32	0.10	Upgrade
Current Ratio	6.85	6.85	0.81	5.88	0.32	0.10	Upgrade
Return on Equity (ROE)	-56.63%	-56.63%	-94.83%	-100.82%	-	-30.58%	Upgrade
Return on Assets (ROA)	-33.44%	-33.44%	-40.62%	-41.84%	-	-10.75%	Upgrade
Return on Capital (ROIC)	-36.65%	-36.65%	-45.13%	-53.20%	-	-13.29%	Upgrade
Earnings Yield	-10.18%	-33.78%	-521.25%	-18.69%	-	-	Upgrade
FCF Yield	-	-24.01%	-242.92%	-21.27%	-	-	Upgrade
Buyback Yield / Dilution	-1011.63%	-1011.63%	-0.45%	-47.98%	-1.45%	-1.47%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.